Tosoh Corp. is a company that specializes in producing and selling a wide range of chemicals and specialty products. The company operates in five main segments: Petrochemicals, Chlor-alkali, Specialty, Engineering, and Others. Within these segments, Tosoh offers various products such as olefins, polymers, caustic soda, vinyl chloride monomer, polyvinyl chloride, high-performance polyurethane, organic chemicals, urethane raw materials, cement, inorganic or organic fine products, measurement and diagnostic products, electronic materials, water treatment equipment, construction, transportation and warehousing, inspection and analysis, and information processing. Tosoh Corp. was established in 1935 and is headquartered in Tokyo, Japan.

Drugs associated with Tosoh Corp.

RD-42024

Target

DNA-directed DNA polymerase

Mechanism

DNA-directed DNA polymerase inhibitors

Active Org.-

Originator Org.

Rational Drug Design Laboratories

Active Indication-

Inactive Indication

HIV Infections

Drug Highest PhasePending

First Approval Ctry. / Loc.-

First Approval Date-

sIL-6R (Tosoh)

Target

IL-6

Mechanism

IL-6 modulators

Active Org.-

Originator Org.

Tosoh Corp.

Active Indication-

Inactive Indication

Anemia

Drug Highest PhasePending

First Approval Ctry. / Loc.-

First Approval Date-

Interleukin-6 receptor(Tosoh Corp.)

Target

IL-6

Mechanism

IL-6 stimulants

Active Org.-

Originator Org.

Tosoh Corp.

Active Indication-

Inactive Indication

Hematopoietic stem cell transplantation [+1]

Drug Highest PhasePending

First Approval Ctry. / Loc.-

First Approval Date-

100 Clinical Results associated with Tosoh Corp.

0 Patents (Medical) associated with Tosoh Corp.

1,518

Literatures (Medical) associated with Tosoh Corp.

02 Oct 2024·ACS Applied Materials & Interfaces

Formation of High-Photoresponsivity BaSi₂ Films by Radio-Frequency Sputtering and Evaluation of a BaSi₂/TiN/Glass Heterojunction by Transmission Electron Microscopy

Article

Author: Toko, Kaoru ; Mesuda, Masami ; Suemasu, Takashi ; Du, Rui ; Takenaka, Haruki ; Sato, Takumi ; Koda, Yoichiro

Barium disilicide (BaSi₂) is a thin-film solar cell material composed of abundant elements, and its application potential is further enhanced by its formation on inexpensive substrates, such as glass. The effect of the substrate temperature on the co-sputtering of BaSi₂ and Ba targets to form BaSi₂ films on Si(111) and TiN/glass substrates was investigated. Contrary to expectations, the photoresponsivity reached maximum values exceeding 5 and 2 A W^-1, respectively, the highest value ever reported for as-deposited samples formed at 750 °C, more than 100 °C higher than those reported previously. Because the photoresponsivity is proportional to carrier lifetime, this result indicates that high-temperature growth can bring out the high performance of BaSi₂ as a light-absorbing layer. Because amorphous SiC (a-SiC) has a larger forbidden band gap and electron affinity than BaSi₂, it is considered suitable as an electron transport layer (ETL) material for BaSi₂ solar cells. On the basis of this, the formation of BaSi₂ (absorption layer)/a-SiC (ETL)/TiN (electrode)/glass heterojunctions was also attempted, and the layered structure was examined by cross-sectional transmission electron microscopy (TEM). Polycrystalline BaSi₂ films were found to be even on the amorphous layer by TEM. A high photoresponsivity of over 2 A W^-1 was obtained. Therefore, the BaSi₂/a-SiC/TiN structure provides a guideline for the structural design of BaSi₂-based thin-film solar cells on glass.

25 Sep 2024·ACS Central Science

A Practical and Sustainable Ni/Co-Free High-Energy Electrode Material: Nanostructured LiMnO₂

Article

Author: Kondo, Sayaka ; Nakayama, Masanobu ; Takada, Koji ; Ugata, Yosuke ; Fujii, Yasuhiro ; Miyaoka, Yuka ; Sato, Takahito ; Glushenkov, Alexey M. ; Sharma, Neeraj ; Hiroi, Satoshi ; Goonetilleke, Damian ; Yabuuchi, Naoaki ; Nakano, Koki ; Oguro, Yuna ; Ohara, Koji

Ni/Co-free high-energy positive electrode materials are of great importance to ensure the sustainability of Li-ion battery production and its supply chain in addition to minimizing environmental impact. Here, nanostructured LiMnO₂ with both orthorhombic/monoclinic layered domains is synthesized, and its lithium storage properties and mechanism are examined. High-energy mechanical milling is used to convert the metastable and nanosized LiMnO₂ adopting the cation-disordered rocksalt structure to an optimal domain-segregated layered LiMnO₂. This positive electrode produces an energy density of 820 W h kg^-1, achieved by harnessing a large reversible capacity with relatively small voltage hysteresis on electrochemical cycles. Moreover, voltage decay for cycling, as observed for Li-excess Mn-based electrode materials, is effectively mitigated. Furthermore, by determining the structure-property relationships of different LiMnO₂ polymorphs, LiMnO₂ with similar domain structure and surface area is successfully synthesized with an alternative and simpler method, without the metastable precursor and high-energy mechanical milling. The cyclability of domain-containing LiMnO₂ is also improved with the use of a highly concentrated electrolyte coupled with a lithium phosphate coating due to the suppression of Mn dissolution. These findings maximize the possibility of the development of high-energy, low-cost, and practical rechargeable batteries made from sustainable and abundant Mn sources without Ni/Co.

01 Jun 2024·Analytical Sciences

Detection of estradiol with a digital immunoassay using an anti-immunocomplex antibody and single-molecule observation of gold nanoparticles

Article

Author: Muto, Yu ; Hirao, Gen ; Zako, Tamotsu

Gold nanoparticles (AuNPs) have been widely applied to molecular sensors due to their optical properties. We previously reported a molecular detection by observing the scattered light of AuNPs at a single nanoparticle level using dark field microscopy (DFM). Recently, a molecular detection method using digital immunoassay has been reported, taking advantage of the characteristics of DFM. However, the digital immunoassays reported so far have been performed by a conventional sandwich immunoassay, which is difficult to apply to the detection of small molecules. In this study, with the aim of small molecule detection, we developed a digital immunoassay method using an anti-immunocomplex antibody that specifically recognizes immunocomplexes of small molecules with antibodies. The number of AuNPs modified with anti-immunocomplex antibody bound to immunocomplex of estradiol and anti-estradiol antibody was counted at a single nanoparticle level using DFM. We demonstrated for the first time that estradiol molecule can be detected by digital immunoassay using DFM and an anti-immunocomplex antibody with a detection sensitivity of 1 pg/mL.

News (Medical) associated with Tosoh Corp.

27 Dec 2023

·www.businesswire.com

The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition - COVID-19 Impact, Regions of Market Influence and What to Watch For Long-Term - ResearchAndMarkets.com

DUBLIN--( BUSINESS WIRE )--The "Worldwide Market for In Vitro Diagnostic Tests, 16th Edition" report has been added to ResearchAndMarkets.com's offering. The 16th edition of The Worldwide Market for In Vitro Diagnostic Tests is based on vendor reporting, interviews, vendor activities, and more on a global scale. This dynamic market is projected to grow over the next five years, and this resource describes all of the ways that will happen, which areas are hot and cold, and which companies stand to benefit. The 16th edition of the Worldwide Market for In Vitro Diagnostic Tests is a must have for anyone interested or involved in the IVD industry. Having a guide for the state of IVD and its future is a vital part of making well-informed decisions. The 16th edition of the Worldwide Market for In Vitro Diagnostic Tests provides readers with reliable estimates, real-world forecasts, and insights needed to understand the IVD market in its entirety. Every significant test category in IVD is given a chapter with sub-segments. It's like having ten market research reports in one. Published since 1999, this 1,500+ page report is based on vendor reporting, interviews, vendor activities, and more on a global scale. This full assessment of the IVD diagnostic market makes The Worldwide Market for In Vitro Diagnostics Tests the most trusted report by top companies in the industry. The report has complete IVD market research sections with test segment estimates and forecasts in: Clinical Chemistry, Hematology, Histology, Company Profiles and Rankings, Molecular, Immunoassay, Infectious Disease, Coagulation, Blood Bank IVD, and Point of Care. This is a very significant segment in in vitro diagnostics. The Worldwide Market for In Vitro Diagnostic Tests is the result of months of analysis and review of secondary sources by seasoned analysts, critical readings of current and historic company filings and releases, interviews with relevant experts and searching of government sources and journal literature. All test segments contain valuable information on current market size and future projection. Compound annual growth rate is provided, as well as significant IVD companies in the market and IVD manufacturer's product innovations. This detailed look at the IVD market yields unparalleled global market modeling. Why The Worldwide Market for In Vitro Diagnostic Tests? Maximum Value: One Report, All Segments, World Markets Published Since 1999, by an Expert Firm That Focuses on IVD and Related Healthcare Profiles of 300+ Companies in the Market, Detail on the Top 40 Filled with Industry-Utilized and Business Planning Numbers Learn Who is Launching Products and Investing in the IVD Industry Overall IVD Markets for Every Significant Nation, Detail for Major Markets Based on Latest Financial Reporting, Real-World Industry and Medical Practice Trends This report gives you definitive answers to important questions, including: What is the Size of IVD Market Segments? Within Those Segments, How Do They Break Down? Where Will Those Markets be In Five Years? How Has the IVD Market Changed Over Time? Who's Winning? Who's Merged? Who's Launched Game-Changing Products? What is the Competitive Landscape? Who Can I Partner With? Where are the Growth Markets I Can Enter or Buy Into? And More. The most essential report on the IVD industry, The Worldwide Market for In Vitro Diagnostic Tests, is a must-have tool for understanding the IVD market on a deeper level. Companies profiled include these, and many others: Abbott Diagnostics Accelerate Diagnostics, Inc. Altona Diagnostics Amoy Diagnostics Co. Ltd. Angle Arkray ARUP Laboratories Ascensia Diabetes Care Holdings AG Beckman Coulter Becton Dickinson (BD) BGI Genomics (formerly Beijing Genome Institute) Binding Site Group Ltd. (The) Biocartis Biocept, Inc. Biohit Biomerica Inc. bioMerieux Bio-Rad BioReference Laboratories Bio-Techne Corporation Biotheranostics Bruker CareDx, Inc. CellaVision AB Cepheid Cepheid / Danaher Cerner Corp. Copan Corgenix Medical Corporation Critical Diagnostics Curetis Cynvenio Biosystems (LungLife AI) Dako A/S Danaher Dexcom Inc. Diagnostica Stago, S.A.S. DIAGON Kft. Hungary DiaSorin Edico Genome (Illumina) Eiken Chemical Co., Ltd EKF Diagnostics Holdings Plc ELITech Group S.A.S. Epic Sciences Epigenomics AG ERBA Diagnostics, Inc. Fujirebio Fujirebio Diagnostics, Inc. Genomic Health (Exact Sciences) Greiner Bio-One International GmbH Grifols Guardant Health, Inc. Hain Lifescience GmbH Hologic Horiba Medical HTG Molecular Diagnostics Human Longevity Inc. Illumina Immucor Immunodiagnostic Systems (IDS) INOVA Diagnostics, Inc. Instrumentation Laboratory Lab Corp Leica Biosystems LifeScan Inc. Luminex Corporation Medica Corporation MedTest DX Menarini Diagnostics Meridian Bioscience, Inc. MilliporeSigma Mindray Nova Biomedical Perkin Elmer PerkinElmer, Inc. (PE) Qiagen Quest Quest Diagnostics Quidel Ortho Radiometer Randox Randox Laboratories Ltd. Rennova Health, Inc. Response Biomedical Corp. Roche Diagnostics SD Biosensor Seegene Sekisui Diagnostics LLC Shimadzu Scientific Instruments Siemens Healthineers Singulex, Inc. Snibe Co. Ltd. Sonic Healthcare Sysmex Tecan Group Thermo Fisher Scientific Tosoh Bioscience Trinity Biotech Plc Werfen For more information about this report visit https://www.researchandmarkets.com/r/p3ecam About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Diagnostic Reagents

18 Dec 2023

·www.businesswire.com

Global Hemoglobin A1C Testing Market Forecast to 2028 - Utilizing Data-driven Insights and Innovative Assays for Enhanced Decision-making in Hemoglobin A1C Testing - ResearchAndMarkets.com

DUBLIN--( BUSINESS WIRE )--The "Global Hemoglobin A1C Testing Market, Forecast to 2028" report has been added to ResearchAndMarkets.com's offering. The global hemoglobin A1C (HbA1c) testing market will witness significant growth driven by technological advances and the increasing adoption of point-of-care testing (POCT). Real-time glucose monitoring and conventional HbA1c testing have been integrated, revolutionizing patient care by offering better treatment choices and better results. By streamlining data collection, this integration improves operational effectiveness in healthcare settings. POCT options play a significant role as well, offering on-the-spot HbA1c testing for rapid outcomes and prompt action, further improving patient satisfaction and saving valuable assets. Collaborations between medical device manufacturers, healthcare IT businesses, and pharmaceutical companies determine the competitive landscape in the HbA1c testing market. By promoting industrial convergence and the development of integrated solutions, these partnerships position companies as market leaders with cutting-edge products. Companies that capitalize on this trend early on have an advantage over competitors and create new business prospects by addressing the rising need for all-inclusive diabetes management products. Key Topics Covered: HbA1c Testing Overview Key Competitors Global Diabetes Highlights, 2021 Number of People with Diabetes, 2021-2045 Top 10 Countries or Territories for Number of Adults Growth Metrics Growth Drivers Growth Restraints Forecast Assumptions Revenue Forecast Revenue Forecast Analysis Revenue Forecast by Region Revenue Forecast By Setting Revenue Forecast by End Users Revenue Forecast by Technology Pricing Trends and Analysis Key Pricing Strategies Adopted by Players Future Aspect of Pricing Global HbA1c Testing Market - Notable Activities Global HbA1c Testing Reimbursement Pathways Competitive Environment Companies to Watch - Lab and POC HbA1c Testing Abbott Laboratories Roche Diagnostics Siemens Healthineers Beckman Coulter Tosoh Corporation Bio-Rad Laboratories EKF Diagnostics Erba Diagnostics, Inc. Diazyme Laboratories PTS Diagnostics Trinity Biotech Competitive Mapping by HbA1c Offering Parameters Growth Opportunity Universe Growth Opportunity Summary Growth Opportunity 1 - Tailoring HbA1c Testing Approaches to Individual Patient Characteristics Growth Opportunity 2 - Advancements in POCT for Accurate, Affordable, and User-friendly HbA1c Testing Growth Opportunity 3 - Capturing Opportunities in Growing Diabetes Care Markets Growth Opportunity 4 - Diabetes HbA1c Screening for Better Care and Management For more information about this report visit https://www.researchandmarkets.com/r/lozvz8 About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

11 Sep 2023

·www.prnewswire.com

Global Immunoassay Market Strategies & Trends Report 2023-2027: From Clinical to Consumer - Immunoassay's Expanding Footprint in Diagnostics

DUBLIN, Sept. 11, 2023 /PRNewswire/ -- The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. In the ever-evolving landscape of the diagnostic industry, immunoassay is emerging as a steadfast workhorse, finding new relevance driven by the demands of the ongoing pandemic. The need for rapid, easily accessible diagnostics has propelled immunoassay to the forefront, as it adapts and advances in response to shifting market dynamics. Advancements in genetic knowledge are opening up new avenues for immunoassay technologies, with multiplex capabilities becoming the standard. This transformation extends to rapid diagnostics, point-of-care solutions, biomarker exploration, and the expanding consumer market, while traditional immunoassay methods continue to hold a strong position within the growing realm of clinical diagnostics. Within the realm of immunoassay instrumentation, multiple factors are fueling growth, including ongoing diagnostic breakthroughs, the retirement of older instruments driven by evolving technologies, wider consumer adoption, and the maturation of immunity-related technology. However, these opportunities are not without their challenges. Heightened competition is exerting downward pressure on prices, while the threat from PCR-based instruments looms. Lower barriers to entry and potential drawbacks associated with wellness trends also present limitations to growth. This dynamic landscape is characterized by enduring instruments, industry structures in flux due to declining instrument costs, and meticulous instrument specifications, which play a pivotal role in shaping the field. Innovations like CRISPR diagnostics further contribute to the evolving immunoassay landscape. With profiles of over 60 companies, spanning both large and small players in this field, this comprehensive report offers invaluable insights into the pitfalls and opportunities that define the immunoassay industry. It equips stakeholders to make informed investment decisions and valuations, providing the latest data to navigate this ever-changing landscape with confidence. Key Topics Covered: Industry Overview Players in a Dynamic Market Academic Research Lab Diagnostic Test Developer Instrumentation Supplier Chemical/Reagent Supplier Pathology Supplier Independent Clinical Laboratory Public National/regional Laboratory Hospital Laboratory Physicians Office Lab (POLS) Audit Body Certification Body The Clinical Laboratory Market Segments Traditional Market Segmentation Laboratory Focus and Segmentation Hospital Testing Share Economies of Scale Hospital vs. Central Lab Physician Office Lab's Physician's and POCT Immunoassay - Markets and Discussion Instruments - Genetics changes the picture RIA - A Technology Shows its Age Immunoassay vs. PCR vs. Sequencing - A See Saw Battle The Smart Shrinking Instrument - Serious Implications Research Funding and Capital Expense - Instrument Pooling Multiplex vs. POC - A Tradeoff Analysis Reagents and Kits - Genetics changes the picture Bigger Test Menus a Boon for Kit Market Physician Office Labs - A New Frontier Rapid and POCT to Threaten Instrument Markets OTC and DTC - Huge Market Potential Economies of Scale. Going Away? Lower Barriers to Entry for Instruments/Analyzers Miniturization and Technology Drive Acquisition Immunoassay Recent Developments Recent Developments - Importance and How to Use This Section EDP Biotech, New Day Diagnostics to Merge Sorrento Therapeutics Nabs Contract for Dx Platform Beckman Coulter Diagnostics DxI 9000 Access Immunoassay Analyzer Qorvo Eyes Multiplex Immunoassay BioMerieux Launches New Products Senzo to Commercialize Infectious Disease Lateral Flow Tests Nanomix Plans Instrument, Test Launches Startup GLX Analytix Prepares for Commercialization Nonagen Gets CE Mark for Bladder Cancer Immunoassay Qualigen Acquires Majority Stake in NanoSynex Saladax Biomedical Using Immunoassay Dx Prolight Diagnostics to Acquire Psyros Diagnostics Quidel to Acquire Ortho Clinical Diagnostics FDA Grants EUA to Xtrava Health Alamar Biosciences Develops Immuno-Sandwich Platform FDA grants breakthrough device to multiplex immunoassay Quidel, Beckman Settle Cardiac Immunoassay Dispute BGI Americas, Advaite Form SARS-CoV-2 Testing Partnership BioMerieux Gets CE Mark for Three Dengue Immunoassays COVID-19 Portfolio to Accelerate At-Home Infectious Disease Testing Roche Diagnostics Expanding Testing Portfolio in 2021 PerkinElmer Long-Term Outlook Quidel Updates Outlook for C19 Testing Dx Companies Look at Multiplex Tests for SARS-CoV-2, Influenza Becton Dickinson and NAT Diagnostics Acquisition Market Trends Factors Driving Growth Diagnostic Factors Changing Technologies Spur Early Instrument Retirement Consumer Channels Open Wider Immunity Technology Comes of Age Factors Limiting Growth Increased Competition Lowers Price Threat from PCR Based Instruments Lower Barriers to Entry Wellness has a downside Immunoassay Instrumentation Instrumentation Tenacity Declining Cost of Instruments Changes Industry Structure LISTING of INSTRUMENT SPECIFICATIONS Immunoassay - CRISPR Diagnostics Market Guides Immunoassay Market - Strategic Situation Analysis Guide for Executives, Marketing, Sales and Business Development Staff Guide for Management Consultants and Investment Advisors Market Definition Immunoassay Markets Definition In This Report Enzyme Based Immunofluorescence Chemiluminescence DNA/NAT RIA & Other Reagents/Kits, Analyzers, Software & Services Infectious Disease Auto Immune Endocrinology Oncology Cardiology Other Specialty Market Definition Methodology Perspective: Healthcare and the IVD Industry Global Healthcare Spending Spending on Diagnostics Important Role of Insurance for Diagnostics Appendices United States Medicare System: Laboratory Fees Schedule The Most Used IVD Assays The Highest Grossing Assays Profiles of Key Companies Abbott Laboratories Abcam Abionic Accel Diagnostics Applied BioCode Arlington Scientific Arrayit Corporation Atomo Diagnostics Aureum Diagnostics Aurora Biomed Autobio Diagnostics AVIVA Systems Biology Awareness Technology Axis-Shield Diagnostics Ltd. Beckman Coulter Diagnostics Becton, Dickinson and Company Biocartis Biomatik bioMerieux Diagnostics Bioneer Corporation Bio-Rad Laboratories, Inc. BioTek Instruments Boditech Med, Inc Boster Biological Technology Diamedix (Erba Diagnostics) Diasorin S.p.A. Dynex Technologies Enzo Biochem Eurofins Scientific FUJIFILM Wako Diagnostics Fujirebio Gold Standard Diagnostics Grifols Hycor Biomedical Immunodiagnostic Systems (IDS) Immunodiagnostik AG Inova Diagnostics JR Biomedical Luminex Corp Maxim Biomedical Mbio Diagnostics Meso Scale Discovery Millipore Sigma Mindray Molecular Devices MP Biomedical Operon Ortho Clinical Diagnostics Perkin Elmer Qiagen Quidel R&D Systems Randox Toxicology Roche Molecular Diagnostics SD Biosensor Siemens Healthineers Sysmex Tecan Thermo Fisher Scientific Inc. TOSOH Bioscience Veredus Laboratories Vircell YD Diagnostics Zhejiang Orient Gene Biotech Scope of the Report Global Market by Application Endocrinology Applications Immune Applications Oncology Applications Infectious Disease Applications Cardiology Applications Other Applications Immunoassay by Technology Enzyme Flourescence Chemiluminescence Nucleic Acid Rapid/POC Other Technology Immunoassay by Product Instrument Reagents Services Immunoassay by User Hospital Outpatient Lab POC/Other 12 Vision of the Future of Immunoassay For more information about this report visit About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Media Contact: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Logo: SOURCE Research and Markets

AcquisitionDiagnostic ReagentsImmunotherapy

100 Deals associated with Tosoh Corp.

100 Translational Medicine associated with Tosoh Corp.

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 21 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Interleukin-6 receptor(Tosoh Corp.) ( IL-6 )	Hematopoietic stem cell transplantation More	Pending
RD-42024 ( DNA-directed DNA polymerase )	HIV Infections More	Pending
sIL-6R (Tosoh) ( IL-6 )	Anemia More	Pending

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis